| 000 | 05518nam a22004575i 4500 | ||
|---|---|---|---|
| 999 |
_c362555 _d362555 _x1 |
||
| 001 | 362555 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102121552.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 210707s2021 sz | s |||| 0|eng d | ||
| 020 | _a9783030688585 | ||
| 024 | 7 |
_a10.1007/978-3-030-68858-5 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aRC270.3.T65 _b2021 EB |
|
| 245 | 0 | 0 |
_aAtlas of Clinical PET-CT in Treatment Response Evaluation in Oncology _cedited by Stefano Fanti, Gopinath Gnanasegaran, Ignasi Carrió |
| 250 | _aFirst edition 2021 | ||
| 264 | 1 |
_aCham _bSpringer International Publishing _c2021 |
|
| 300 |
_a1 recurso en línea (XIII, 488 páginas) _b340 ilustraciones, 316 ilustraciones a color |
||
| 336 |
_2rdacontent _aTexto _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_aArchivo de texto _bPDF |
||
| 505 | 0 | _aPART I General Chapters: Introduction to Treatment response evaluation: Science and Practice -- CT in Treatment response evaluation - Overview -- MRI & Diffusion weighted MRI in Treatment response evaluation- Overview -- PET & PET-CT in Treatment response evaluation-Overview -- Conventional Radiological Techniques and PET-CT in Treatment response evaluation in post-surgical setting -- Conventional Radiological Techniques and PET-CT in Treatment response evaluation in chemotherapy setting -- Conventional Radiological Techniques and PET-CT in Treatment response evaluation in radiation oncology -- Conventional Radiological Techniques and PET-CT in Treatment response evaluation in Immunotherapy settings -- Treatment response evaluation of bone metastases using 18F-NaF -- How to report PET-CT scans in post therapy scenarios: Do's and don'ts -- PART II Atlas Articles: 18F-FDG & Non FDG PET-CT in Treatment response evaluation in Head and neck cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in lung cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in neuro-oncology -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in hepatobiliary cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in gastroesophageal cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in Lymphoma and Non-hodgkins lymphoma -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in breast cancer -- 18F-FDG, 18F-Choline & 68Ga-PSMA PET-CT in Treatment response evaluation in prostate cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in gynaecological cancers -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in colorectal cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in soft tissue sarcomas -- FDG & Non FDG PET-CT in Treatment response evaluation in malignant melanoma -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in myeloma -- FDG PET-CT & 18F-NaF in Treatment response evaluation in bone metastases and bone tumours -- 18F-FDG & Non FDG PET-CT in Assessment of treatment response in paediatric oncology -- 68Ga-DOTA PET-CT in Treatment response evaluation in NETs -- 18F-DOPA PET-CT in Treatment response evaluation -- 18F-FLT PET-CT in Treatment response evaluation -- Brain PET-CT in Treatment response evaluation. | |
| 520 | _aThis text atlas is a superb guide to the use of PET-CT for the evaluation of treatment response in oncology patients based on its ability to assess tumor metabolic status. The first part of the book explains the role of PET-CT in response evaluation in different treatment settings. For comparison, overviews of the value and limitations of CT alone, PET alone, and anatomical and functional MRI are included. Guidance is also provided on the reporting of PET-CT scans in post-therapy scenarios. The second part of the book describes and illustrates the use of PET-CT with FDG and other tracers to assess the treatment response of malignancies at different anatomic sites. Featuring a wealth of images, informative case-based discussion, and evidence-based teaching points, these disease-specific chapters clearly demonstrate the key role that PET-CT can play in distinguishing early responders from patients who are non-responders or are resistant to treatment. Prompt and accurate evaluation of treatment response is vital as we enter the era of individualized medicine, and this atlas will persuade readers of the considerable advantages of PET-CT over conventional radiological and clinical methods. | ||
| 988 | _aSpringer_Medicine_2021 | ||
| 650 | 7 |
_2embne _9159703 _aTomografía por emisión |
|
| 650 | 7 |
_2embne _9326334 _aCáncer _xTomografía por emisión |
|
| 650 | 7 |
_2embne _aOncología _9139207 |
|
| 700 | 1 |
_aFanti, Stefano _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _988787 |
|
| 700 | 1 |
_aGnanasegaran, Gopinath _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _998468 |
|
| 700 | 1 |
_aCarrió, Ignasi _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _91985 |
|
| 776 | 0 | 8 |
_iPrinted edition: _z9783030688578 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783030688592 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-68858-5 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b02/2022 _dz _esc _zSI |
||